Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

The Canadian Nosocomial Infection Surveillance Program


CNISP - PCSIN

Vancomycin - Resistant Enterococci (VRE) Surveillance

1998-present

Publications/Presentations
Protocol PDF
Data Collection Form PDF
Working Group

Laboratory-based surveillance (E. faecium or E. faecalis with MIC > 8 μg/ml) with chart review for demographic and clinical data. From 1998 to 2005 a total of 3039 new cases of VRE were identified.

VRE per 1000 patient admissions
  1999 2000 2001 2002 2003 2004 2005
Overall 0.37 0.5 0.39 0.64 0.64 0.77 1.32
Colonizations 0.34 0.45 0.36 0.58 0.58 0.71 1.25
Infections 0 0 0 0.1 0.1 0.1 0.1

 

VRE per 100 000 patient admissions
  1999 2000 2001 2002 2003 2004 2005
Overall 5.34 7.32 4.71 7.92 7.68 9.93 15.52
Colonizations 5 6.62 4.37 7.23 6.97 9.93 14.7
Infections 0.32 0.64 0.26 0.7 0.66 0.63 0.57

 

VRE per 100 Enterococci isolates
  1999 2000 2001 2002 2003 2004 2005
Overall 1.16 0.83 0.54 0.52 0.55 1.48 3.25
Colonizations 1.11 0.73 0.46 0.47 0.53 1.42 3.11
Infections 0.1 0.1 0.1 0.1 0 0.1 0.12

 

Incidence of VRE/1000 admissions